TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222.

Halle C F Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.